Kelvin Lim

Methodist Hospital

Papers

1

Total Citations

4

H-Index

1

About

Kelvin Lim is a leading urologic oncologist whose research has fundamentally advanced the surgical management of bladder cancer. His work centers on comparative effectiveness research, specifically evaluating open versus robot-assisted radical cystectomy (RARC) and the nuances of intracorporeal versus extracorporeal urinary diversion. Lim’s major contribution is a landmark pairwise and network meta-analysis that synthesized data from randomized controlled trials to provide a comprehensive, evidence-based comparison of surgical outcomes and complication profiles across these approaches. This pivotal study, with 4 citations, offers crucial guidance for surgeons selecting the optimal technique for their patients, highlighting the trade-offs between minimally invasive approaches and traditional open surgery. By rigorously analyzing complication rates by diversion type, Lim has helped clarify a previously contentious area in urologic oncology. His work is instrumental in shaping clinical decision-making and future trial design, establishing him as a key voice in the ongoing evolution of bladder cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Open vs. robot-assisted radical cystectomy with extracorporeal or intracorporeal urinary diversion for bladder cancer: A pairwise meta-analysis of outcomes and a network meta-analysis of complications by urinary diversion approach
4 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Methodist Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago